Carina BALCOS, Norina FORNA, Ramona Feier, Teona Tudorici
Cardiovascular diseases are a major group of diseases with increased prevalence among the population. Antihypertensive drugs are incriminated as responsible for reducing salivary flow and harm to oral health. The purpose of this study was to evaluate the influence of cardiovascular disease and implicitly of cardiovascular medication on salivary parameters in patients with cardiovascular disease. Material and method. The cross-sectional study was conducted on 30 patients, an average age of 60.47 years. Subjects completed a questionnaire with general data and were clinical examined. The Saliva-Check Buffer (GC) tests were used to determine salivary pH, salivary flow and buffer capacity. Statistical analysis was performed with SPSS 14.0. Results: 50% of them had hypertension, treated with one type of antihypertensive drug, 73.3% using beta-blockers. 80% of subjects have a low salivary secretion, 53% have a reduced buffer capacity, 90% of subjects have a very low and low salivary pH. 86% of the subjects had dental caries and periodontal disease. Most of the subjects with monotherapy presented the lowest acidic pH cases. The saliva buffer capacity was lower for multi-therapy subjects. Conclusions: Cardiovascular disease is accompanied by changes in oral cavity homeostasis. Prevalence of dental caries, periodontal disease and edentation presented elevated values among subjects with cardiovascular disease.